# Takeda clinical trials: 1,026 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,026 trials with Takeda as lead sponsor, 84 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Takeda: 1,026 rows for $51.30, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/takeda

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,026
- Recruiting or not yet: 84
- Read on: November 19, 2026

## Trials

The 25 newest of 1,026, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07903220 | A Study About Treatment Use in Adults With Narcolepsy Type 1 (NT1) in Europe and Canada | Takeda | Observational | Not yet recruiting | Narcolepsy Type 1 | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903220) |
| October 13, 2026 | NCT07871721 | A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) | Takeda | Phase 3 | Not yet recruiting | Psoriatic Arthritis | 644 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871721) |
| October 9, 2026 | NCT07868107 | A Study of Secondary Immunodeficiencies in Adults With Blood Cancers in Kazakhstan Who Have a Weakened Immune System (K-SIDE Study) | Takeda | Observational | Not yet recruiting | Secondary Immunodeficiency (SID) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868107) |
| October 9, 2026 | NCT07868081 | A Study to Better Understand the Diagnosis and Treatment of Polycythaemia Vera | Takeda | Observational | Not yet recruiting | Polycythemia Vera | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868081) |
| August 31, 2026 | NCT07794735 | A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been Treated With Immunoglobulins | Takeda | Phase 4 | Not yet recruiting | Primary Immunodeficiency Diseases (PID) | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794735) |
| August 14, 2026 | NCT07765602 | A Study of Rusfertide in Adults With Polycythemia Vera in China | Takeda | Phase 2 | Not yet recruiting | Polycythemia Vera | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765602) |
| August 7, 2026 | NCT07752108 | A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis | Takeda | Phase 3 | Not yet recruiting | Palmoplantar Psoriasis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07752108) |
| June 15, 2026 | NCT07648030 | A Study of Rusfertide in Japanese Adults With Polycythemia Vera | Takeda | Phase 2 | Recruiting | Polycythemia Vera | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648030) |
| June 15, 2026 | NCT07646678 | A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia | Takeda | Phase 2/3 | Recruiting | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646678) |
| June 8, 2026 | NCT07633301 | A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy) | Takeda | Phase 2 | Recruiting | Narcolepsy Type 1 | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07633301) |
| June 3, 2026 | NCT07623174 | A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland | Takeda | Observational | Recruiting | Metastatic Colorectal Cancer | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623174) |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623161) |
| May 29, 2026 | NCT07613359 | A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant | Takeda | Phase 2 | Recruiting | Antibody-Mediated Rejection (AMR) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613359) |
| March 27, 2026 | NCT07494058 | A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico | Takeda | Observational | Terminated | Lysosomal Disease | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07494058) |
| March 3, 2026 | NCT07445087 | A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea | Takeda | Observational | Recruiting | Hereditary Angioedema (HAE) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445087) |
| February 27, 2026 | NCT07436728 | A Study of TAK-505 in Adults With Solid Tumors | Takeda | Phase 1/2 | Recruiting | Malignant Solid Tumors | 151 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07436728) |
| February 24, 2026 | NCT07429942 | A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant... | Takeda | Observational | Recruiting | Thrombotic Thrombocytopenic Purpura (TTP) | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07429942) |
| February 20, 2026 | NCT07422480 | A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need... | Takeda | Phase 3 | Recruiting | Myelodysplastic Syndrome, Anemia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422480) |
| February 11, 2026 | NCT07404644 | An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD) | Takeda | Observational | Recruiting | Von Willebrand Disease (vWD) | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07404644) |
| February 11, 2026 | NCT07403968 | A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease | Takeda | Phase 2 | Recruiting | Crohn's Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07403968) |
| February 6, 2026 | NCT07392450 | A Study of TAK-755 in Adults With Acute Ischemic Stroke | Takeda | Phase 2 | Recruiting | Acute Ischemic Stroke | 222 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07392450) |
| January 23, 2026 | NCT07363720 | A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy | Takeda | Phase 3 | Active not recruiting | Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07363720) |
| January 20, 2026 | NCT07353099 | A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma | Takeda | Observational | Recruiting | Thrombotic Thrombocytopenic Purpura (TTP) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07353099) |
| January 6, 2026 | NCT07319845 | A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes | Takeda | Phase 2 | Recruiting | Myelodysplastic Syndromes | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07319845) |
| January 6, 2026 | NCT07319832 | A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome | Takeda | Observational | Recruiting | Short Bowel Syndrome (SBS) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07319832) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 175 |
| Phase 1/2 | 29 |
| Phase 2 | 153 |
| Phase 2/3 | 18 |
| Phase 3 | 315 |
| Phase 4 | 73 |
| Not applicable | 10 |
| Observational | 253 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 768 |
| Terminated | 92 |
| Recruiting | 75 |
| Withdrawn | 40 |
| Active not recruiting | 35 |
| Not yet recruiting | 9 |
| Available | 4 |
| No longer available | 2 |
| Approved for marketing | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 101 |
| Diabetes Mellitus | 70 |
| Crohn Disease | 68 |
| Colitis, Ulcerative | 48 |
| Dyslipidemias | 47 |
| Hypertension | 42 |
| Glucose Metabolism Disorders | 41 |
| Gastroesophageal Reflux | 31 |
| Diabetes Mellitus, Lipoatrophic | 27 |
| Sleep Initiation and Maintenance Disorders | 25 |
| Inflammatory Bowel Diseases | 22 |
| Multiple Myeloma | 22 |
| Hyperlipidemias | 21 |
| Depressive Disorder, Major | 20 |
| Angioedemas, Hereditary | 19 |
| Duodenal Ulcer | 18 |
| Carcinoma, Non-Small-Cell Lung | 18 |
| Dengue | 17 |
| Hypercholesterolemia | 15 |
| Gout | 15 |
| Essential Hypertension | 14 |
| Cardiovascular Diseases | 14 |
| Stomach Ulcer | 14 |
| Colorectal Neoplasms | 12 |
| Neoplasms | 10 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Psychiatric hospitals in the United States](https://specstream.ai/data/businesses/psychiatric-hospitals/united-states)
- [Mongolian restaurants in the United States](https://specstream.ai/data/businesses/mongolian-restaurants/united-states)
- [Hydraulic repair companies in the United States](https://specstream.ai/data/businesses/hydraulic-repair-companies/united-states)
- [Estate planning law firms in the United States](https://specstream.ai/data/businesses/estate-planning-law-firms/united-states)
- [Cleaning companies in the United States](https://specstream.ai/data/businesses/cleaning-companies/united-states)
- [B2B food products companies in the United States](https://specstream.ai/data/businesses/b2b-food-products-companies/united-states)
